Temperatures hit 82 degrees in Washington, D.C., Wednesday, one of the highest readings the city has ever experienced in February. And for the second day in a row, Boston set a high-temperature record for a February day: 71 degrees.
In New York’s Central Park, the temperature hit 78 degrees, the highest ever recorded in February. The milestone shattered the record for Feb. 21, which had previously stood at 68 degrees, back in 1930.
“We’re not breaking daily records, we’re breaking all-time temperature records,” said Andrew Freedman, senior science editor of Mashable.
According to Freedman, part of the explanation lies in an unusual disturbance of the polar vortex, which in the past week has split in two, producing two distinct cold waves across the globe.
“You had one portion of it moving into the Western U.S. and Canada, while at the same time one portion of it moved into Europe and Eurasia,” Freedman said. “So those are the two cold spots in the Northern Hemisphere right now. And in the eastern U.S., suddenly we had this incredible warm-up today and on Tuesday.”
Freedman explained the split in the polar vortex. “Normally, you have this circulation of fast winds in the upper levels of the atmosphere over the Arctic. Usually, it stays put; it behaves well.” But this year the planet experienced what Freedman called a Sudden Stratospheric Warming event. “You had energy from the lower atmosphere go up to the upper atmosphere and sort of knocked it off balance.”
Freedman added that climate change is also contributing to the record temperatures on the East Coast. “It’s easier for us to set these high-temperature records as the climate continues to warm,” he said. “That's the bottom line climate message overall.”
And as for what’s ahead, well, Freedman said, on Thursday, “It’s going to snow in Boston.”
Read more at [Mashable](https://mashable.com/2018/02/15/polar-vortex-split-stratospheric-warming-snow-cold-europe-us/).
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
